Health Reform: Industry Benefits, Savings Delayed

The German government’s health reform aimed to reduce spending, particularly within the pharmaceutical industry. However, due to pressure from the industry, the coalition government weakened its plans. This raises questions about the balance between cost savings and pharmaceutical innovation.

Summarized from the sources above. Read the originals for the full story.